logo

For the Inventor, By the Inventor

Osaka, Japan

Mitsuru Ohkubo

This inventor holds 9 USPTO granted patents and 1 EPO patent. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 1991-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuru Ohkubo. Retrieved from https://idiyas.com/inventor/mitsuru-ohkubo-53u50d81

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 44.4


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Kawabe-gun, JP (2002)
  • Hyogo, JP (1991 - 2003)
  • Osaka, JP (2004 - 2008)

Company Filing History:

goldMedal6 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents
silverMedal3 out of 424 
 
Astellas Pharma Gmbh
 patents

Years Active: 1991-2008

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 7442715 - Thiazole derivatives (2008-10-28),
2. 7371842 - Polynucleotide encoding a 35 KDA protein thats binds to WF00144 (2008-05-13),
3. 7125901 - Thiazole derivatives (2006-10-24),
4. 6812235 - Beta-alanine derivatives and their use as receptor anatgonists (2004-11-02),
5. 6538007 - N-[(R)-1-[3-(4-piperidyl)propionyl]-3-piperidylcarbonyl]-2(S)-acetylamino-&bgr;-alanine trihydrate, compositions thereof, and methods for its use (2003-03-25),
6. 6384028 - N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein IIb/IIIa antagonists and fibrinogen-blood platelets binding inhibitors (2002-05-07),
7. 6380215 - Beta-alanine derivative and a process for the preparation thereof (2002-04-30),
8. 5622976 - Oxadiazole derivatives having acetylcholinesterase-inhibitory and (1997-04-22),
9. 5059608 - Bicyclic amine compound and a process for the preparation thereof (1991-10-22),

Title: Mitsuru Ohkubo: Innovator in Pharmaceutical Research

Introduction

Mitsuru Ohkubo is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical research, holding a total of 9 patents. His work primarily focuses on compounds that have therapeutic applications, particularly in the treatment of diabetes and related conditions.

Latest Patents

Ohkubo's latest patents include innovative compounds such as thiazole derivatives. These compounds are designed to act as vascular adhesion protein-1 (VAP-1) inhibitors, which are useful in preventing or treating diseases associated with VAP-1, especially macular edema. Another notable patent involves a polynucleotide encoding a 35 KDA protein that binds to WF00144. This invention aims to regulate sugar production and offers a method for screening compounds that can aid in diabetes treatment.

Career Highlights

Throughout his career, Mitsuru Ohkubo has worked with reputable companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His expertise and innovative approach have led to advancements in drug development and therapeutic solutions.

Collaborations

Ohkubo has collaborated with notable colleagues such as Hisashi Takasugi and Atsushi Kuno, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Mitsuru Ohkubo's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the development of new therapeutic solutions. His work continues to impact the field positively, paving the way for advancements in diabetes treatment and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…